Nsclc Videos
Thomas J. Lynch Jr., MD - Can Emerging Targeted Strategies Improve Outcomes in Advanced NSCLC?
In this educational activity, 3 clinical experts in NSCLC discuss the current state and potential future directions of targeted therapy for ... tags: bevacizumab cancer cell cisplatin erlotinib FLEX gemcitabine
08/11/09 from PeerView Oncology CME/CNE/CPE Audio Podcast
Thomas J. Lynch Jr., MD - Can Emerging Targeted Strategies Improve Outcomes in Advanced NSCLC?
In this educational activity, 3 clinical experts in NSCLC discuss the current state and potential future directions of targeted therapy for ... tags: bevacizumab cancer cell cisplatin erlotinib FLEX gemcitabine
08/11/09 from PeerView Pulmonology CME/CNE/CPE Audio Podcast
Mark A. Socinski, MD - Expanding the Treatment Paradigm in NSCLC: A Clinical Update of Novel ...
In this activity, an expert in non–small-cell lung cancer (NSCLC) highlights key clinical data presented at the 2008 Chicago ... tags: bevacizumab BMS009 CMSTO EGFR erlotinib FLEX gefitinib
12/30/08 from PeerView CME/CE Audio Podcast - Oncology
Alan B. Sandler, MD - Latest Data From Chicago Provide New Insight Into the Evolving Role of ...
In this activity, an expert provides a clinical update on the latest data on adjuvant and neoadjuvant therapy for resectable non-small-cell ... tags: asco cetuximab cisplatin CRT docetaxel EGFR MVP
08/29/08 from PeerView CME/CE Audio Podcast - Oncology
Jyoti D. Patel, MD - Latest Data From Chicago Provide New Insight Into the Evolving Role of ...
In this activity, an expert provides a clinical update on the latest data on molecularly targeted therapies in advanced lung cancer. New ... tags: adenocarcinoma asco bevacizumab cetuximab EGFR erlotinib gefitinib
08/19/08 from PeerView CME/CE Audio Podcast - Oncology
Vincent A. Miller, MD - Unique Toxicity Profile of Antiangiogenic Agents Must Be Considered When ...
In this educational program, an expert describes the unique safety profile of the antiangiogenic agents in lung cancer, and discusses how ... tags: antiangiogenesis NSCLC cytotoxics bevacizumab febrile_neutropenia sunitinib sorafenib
06/12/08 from PeerView CME/CE Audio Podcast - Oncology
Carol S. Viele, MS, RN and Sunil Sharma, MD - Antiangiogenic Therapy in Lung and Colorectal Cancer: ...
In this case-based educational program, experts will discuss how to optimally use angiogensis inhibitors in treatment of advanced lung and ... tags: NSCLC CRC VEGF antiangiogenesis bevacizumab oxaliplatin liver_metastases
03/26/08 from PeerView CME/CE Audio Podcast - Oncology
Ezra Cohen, MD - Integrating Targeted Agents Into Treatment of NSCLC : A Case-Based Approach
In this CME activity, an expert discusses treatment of advanced NSCLC, with a main focus on optimal integration of targeted agents into ... tags: lung_cancer NSCLC targeted_therapy biologics VEGF EGFR erlotinib
10/26/07 from PeerView CME/CE Audio Podcast - Oncology
Roy S. Herbst - Clinical Updates on Targeted Therapy for Lung Cancer
In this activity, experts in the treatment of lung cancer present the most current data on molecularly targeted agents in the treatment of ... tags: asco Avastin bevacizumab biologics EGFR erlotinib gefitinib
09/25/07 from PeerView CME/CE Audio Podcast - Oncology
Mark A. Socinski, MD -Therapeutic Advances in Advanced Non–Small-Cell Lung Cancer: Considering ...
In this program, experts present up-to-date information on treatment of advanced or metastatic NSCLC. Options for first-, -, and third-line ... tags: alternative treatments alternative_treatments asco bevacizumab chemotherapy erlotinib gemcitabine
09/20/07 from PeerView CME/CE Audio Podcast - Oncology